Evidence map›Paper›PMID 41944917›Full record

ArticleAMB Express2026

Multi-omics analysis Taiwanofungus gaoligongensis fermentation with traditional Chinese medicine.

Tingwen He, Zhonghua Chen, Xiaolong Yuan, Churan Li, Yi Wang, Chunting Xiong, Yuan Zhong, Chengbo Peng, Zujiang Kang, Lu Li and 1 more

Abstract read
In one paragraph

Article in AMB Express, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Tingwen HeCollege of Forestry, Southwest Forestry University, Kunming, China.
Zhonghua ChenYunnan Key Laboratory of Biodiversity of Gaoligong Mountain, Yunnan Academy of Forestry and Grass-Land, Kunming, China.
Xiaolong YuanYunnan Key Laboratory of Biodiversity of Gaoligong Mountain, Yunnan Academy of Forestry and Grass-Land, Kunming, China.
Churan LiYunnan Key Laboratory of Biodiversity of Gaoligong Mountain, Yunnan Academy of Forestry and Grass-Land, Kunming, China.
Yi WangYunnan Key Laboratory of Biodiversity of Gaoligong Mountain, Yunnan Academy of Forestry and Grass-Land, Kunming, China. wangyi@yafg.ac.cn.
Chunting XiongCollege of Forestry, Southwest Forestry University, Kunming, China.
Yuan ZhongCollege of Biological and Food Engineering, Southwest Forestry University, Kunming, China.
Chengbo PengCollege of Forestry, Southwest Forestry University, Kunming, China.
Zujiang KangCollege of Forestry, Southwest Forestry University, Kunming, China.
Lu LiYunnan Key Laboratory of Biodiversity of Gaoligong Mountain, Yunnan Academy of Forestry and Grass-Land, Kunming, China.
Yuan ZhengCollege of Forestry, Southwest Forestry University, Kunming, China. zhengyuan_001@126.com.

Funding

Construction Fund supported by Modern Industry School of Edible-fungi, Southwest Forestry University SYJ2501the National Natural Science Foundation of China 32460792the Xingdian Talent Support Program XDYC-QNRC 2022-0245the Yunnan Fundamental Research Projects 202401AS070043
6 · The paper itself

Abstract

This study employed a multi-omics approach to investigate the accumulation of bioactive terpenoids and flavonoids in Taiwanofungus gaoligongensis during liquid culture supplemented with traditional Chinese medicine materials, including Coix lacryma-jobi powder (YM), Astragalus membranaceus powder (HQ), and Pleuropterus multiflorus powder (HSW). Compared with pea flour (WDF), total terpenoid content increased significantly in the HQ and HSW groups, reaching 2.86-fold and 4.23-fold, respectively. Sesquiterpenoids were the predominant class, among which (+ /-)-α-bisabolol and nootkatone in HQ were 8.81-fold and 9.07-fold higher than those in WDF, respectively, whereas drechslerene E in HSW was elevated by 11.17-fold. Flavonoid accumulation was highest in the HQ group, reaching 16.05 times that of WDF, and was primarily composed of isoflavones. Specifically, the levels of maximaisoflavone J, glycitein 1, and formononetin in HQ were 56.59-, 460.39-, and 4570.37-fold higher than those in WDF, respectively. Moreover, the characteristic active component astragaloside IV from A. membranaceus and the flavonoids quercetin and rutin from P. multiflorus were detected in the HQ and HSW fermentation products, respectively. In contrast, potentially hepatotoxic constituents of P. multiflorus, including emodin and anthraquinones, were not detected in the HSW fermentation products, suggesting that co-fermentation with T. gaoligongensis may attenuate the toxicity of P. multiflorus. Transcriptomic analysis revealed that the relative expression levels of multiple genes involved in terpenoid biosynthesis were significantly upregulated in the HQ and HSW groups. In HSW, the expression levels of TgHMGS, TgHMGR, TgMVD, and TgOSC were 2.68-, 2.62-, 2.30-, and 1.86-fold higher than those in WDF, respectively, whereas TgAACT, TgIDI, TgSES, and TgErg25 were upregulated by 2.11-, 1.82-, 2.68-, and 2.25-fold in HQ. These genes may represent key regulatory nodes in the terpenoid biosynthetic pathway of T. gaoligongensis. Furthermore, co-expression trend analysis combined with promoter-binding site prediction suggested that TgZnF10, TgHMG11, and TgZnF19 may regulate the transcriptional activity of TgHMGR, TgPMK, and TgFPPS_2, respectively, while TgErg26, TgErg62, TgErg4, and TgErg5 may be regulated by TgBHLH7, TgBZIP4, TgMYB3, and TgHOX2, respectively. Collectively, these findings provide a theoretical basis for the comprehensive utilization and industrial development of T. gaoligongensis through bidirectional fermentation with Chinese medicinal materials.

Indexed as

Dual-direction fermentationReference-based transcriptome analysisTaiwanofungus gaoligongensisTranscriptional regulationUntargeted metabolomic analysis

Identifiers

PMID41944917
PMCPMC13199547

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.